Wegovy vs Zepbound for Women Over 50: Which GLP-1 Wins?

If you're a woman over 50 researching GLP-1 medications, you've probably noticed something: most clinical trials don't break down results by age and gender together. You're left wondering whether Wegovy or Zepbound works better for your body, at your stage of life, with your hormonal reality. Let's fix that gap with what we actually know from the research, clinical experience, and real patient outcomes.

Understanding What You're Comparing

Both Wegovy and Zepbound are injectable GLP-1 medications approved for weight management, but they work slightly differently in your body. Wegovy contains semaglutide, which mimics one gut hormone (GLP-1) that regulates appetite and blood sugar. Zepbound contains tirzepatide, which mimics two hormones (GLP-1 and GIP), potentially offering a dual mechanism that some studies suggest may lead to greater weight loss.

For women over 50, this distinction matters because your hormonal landscape has shifted. With declining estrogen, many women experience increased insulin resistance, changes in where fat is stored (hello, belly fat), and a metabolism that feels like it's working against you. Both medications address insulin sensitivity and appetite, but they do so through slightly different pathways.

The Weight Loss Numbers: What Women Over 50 Can Expect

In the STEP clinical trials for Wegovy, participants lost an average of 15-17% of their body weight over 68 weeks. The SURMOUNT trials for Zepbound showed even higher numbers, with participants losing an average of 20-22% of body weight at the highest doses.

But here's what's important: while these trials included women in their 50s and 60s, subgroup analyses showed that age itself wasn't a significant barrier to success. Women over 50 responded similarly to younger participants when they stayed on the medication consistently. The difference wasn't age — it was adherence and tolerability.

What does matter for women in this age group is starting context. If you're postmenopausal and have struggled with weight gain despite eating less than you did in your 30s, both medications can help reset that metabolic disadvantage. Zepbound may have a slight edge in total pounds lost, but Wegovy has been around longer and has more long-term safety data specifically in older populations.

Side Effects: The Midlife Reality Check

Let's be honest: GLP-1 medications come with side effects, and some hit differently when you're over 50. Both Wegovy and Zepbound commonly cause nausea, constipation, and decreased appetite. For many women, these effects are manageable and decrease over time.

What we see clinically is that women over 50 sometimes experience more pronounced digestive side effects, particularly constipation. This may relate to naturally slower gut motility with age, compounded by the medication's effects. Staying well-hydrated, increasing fiber gradually, and moving your body daily become non-negotiable parts of treatment success.

Zepbound, because it's newer and includes the GIP mechanism, may cause slightly more initial nausea for some people. However, many patients find that once they adjust, the side effects level out. Wegovy's longer track record means your doctor has more experience managing its side effect profile in older patients.

Considerations for Women Over 50

Several factors specific to this life stage should influence your choice:

Bone health matters more now. Rapid weight loss at any age can affect bone density, but postmenopausal women are already at higher risk for osteoporosis. If you're losing 20%+ of your body weight on Zepbound, working with your doctor on bone health becomes essential. This includes adequate protein intake, resistance training, and potentially calcium and vitamin D supplementation.

Muscle preservation is critical. Women naturally lose muscle mass with age and declining estrogen. Both medications reduce appetite, which can lead to inadequate protein intake and further muscle loss. The goal isn't just weight loss — it's fat loss while preserving lean mass. Zepbound's more aggressive weight loss might require more intentional attention to protein and strength training.

Medication interactions increase with age. Women over 50 are more likely to be on other medications for blood pressure, cholesterol, or thyroid issues. Both Wegovy and Zepbound are generally safe to combine with these medications, but they can affect how your body absorbs oral medications. Your doctor needs the complete picture.

For Women

If you're managing hot flashes, sleep disruption, or mood changes alongside weight concerns, know that weight loss itself may improve some menopausal symptoms. Some women report better sleep and fewer hot flashes after losing weight with GLP-1 medications. However, these medications don't replace hormone therapy if that's something you and your doctor have determined you need. They can work together beautifully as part of a comprehensive approach to midlife health.

For Men

Men over 50 considering these medications often see excellent results, sometimes even more dramatic than women, partly due to higher starting muscle mass and testosterone levels. However, men aren't immune to the side effects and should pay equal attention to protein intake and resistance training. The same metabolic slowdown happens with age, and both medications address it effectively regardless of gender.

What About Cost and Access?

This is where many women over 50 hit a wall. Wegovy and Zepbound both cost $1,000+ monthly without insurance, and many insurance plans don't cover them for weight loss alone — even though obesity is a chronic disease. For women on fixed incomes or nearing retirement, this creates an impossible barrier.

Compounded versions of these medications (semaglutide and tirzepatide) offer the same active ingredients at a fraction of the cost. They're made by FDA-registered compounding pharmacies during FDA-approved drug shortages, providing legal and safe access at prices like $99-299 per month. For women over 50, this cost difference often determines whether treatment is sustainable long-term.

So Which One Wins for Women Over 50?

The honest answer: both can work beautifully, and the "best" choice depends on your individual situation.

Choose Wegovy (or compounded semaglutide) if you want the medication with the longest safety track record, especially if you prefer a slightly gentler approach or have a sensitive stomach. It's been studied more extensively in older populations and has proven cardiovascular benefits.

Choose Zepbound (or compounded tirzepatide) if maximizing weight loss is your primary goal and you're prepared to be diligent about protein intake and side effect management. Its dual-hormone mechanism may offer that extra edge, particularly if you've tried semaglutide before without sufficient results.

But here's what matters most: consistency. The medication that works is the one you can afford, tolerate, and stay on long enough to see results. For many women over 50, that means choosing based on cost and access first, then optimizing from there.

From the Ozari Care Team

We often see women over 50 who've been told their weight gain is "just menopause" and something they need to accept. That's not true. These medications work in your age group, but success requires treating your whole health picture — not just prescribing a shot. That means addressing sleep, stress, muscle preservation, and bone health alongside the medication itself.

Ready to Start Your Journey?

At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team — licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 24, 2026